Compare EHTH & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | EHTH | COCH |
|---|---|---|
| Founded | 1997 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Blank Checks |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.0M | 51.0M |
| IPO Year | 2006 | 2021 |
| Metric | EHTH | COCH |
|---|---|---|
| Price | $1.20 | $0.69 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $3.33 | ★ $6.00 |
| AVG Volume (30 Days) | ★ 228.5K | 97.0K |
| Earning Date | 05-06-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 71.43 | 17.45 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $251,395,000.00 | $241,000.00 |
| Revenue This Year | N/A | $1.58 |
| Revenue Next Year | $5.60 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 45.86 | 7.11 |
| 52 Week Low | $1.14 | $0.36 |
| 52 Week High | $5.89 | $1.89 |
| Indicator | EHTH | COCH |
|---|---|---|
| Relative Strength Index (RSI) | 37.55 | 57.47 |
| Support Level | N/A | $0.63 |
| Resistance Level | $1.58 | $0.77 |
| Average True Range (ATR) | 0.05 | 0.04 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 21.43 | 46.86 |
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is derived from the United States. It also has a presence in China.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.